Placement of an enteral stent is emerging as an effective alternative to surgery for symptomatic relief in patients with malignant gastric outflow and duodenal obstruction. We report experience in a series of patients who had the Wallstent enteral prosthesis inserted. 21 consecutive patients with inoperable obstruction, median age 75 years, had twenty-three procedures for insertion of the Wallstent under fluoroscopic guidance. Stent implantation was successful in 18 patients (86%), all of whom gained relief from nausea and vomiting. There were no short-term complications. Median survival after the procedure was four months (longest ten months), and no deaths were related to insertion.
INTRODUCTION
In a patient with malignant gastroduodenal obstruction, the last few months of life are often dominated by nausea and vomiting, leading on to starvation. Surgical palliation is possible with construction of a bypassing gastrojejunostomy but the morbidity and mortality of surgery are high in these debilitated patients; furthermore, only half gain adequate symptomatic relief. 1, 2 An alternative to surgery in these circumstances is now offered by enteral stents inserted under endoscopic and fluoroscopic guidance. This technique has a good safety record but little has been reported on long-term clinical outcomes. We report here our 3-year experience with endoscopic insertion of the Wallstent to relieve malignant gastrointestinal outflow obstruction.
METHODS

consecutive patients with malignant upper gastro-
intestinal strictures were prospectively studied. Their disease was beyond surgical cure and all had nausea and vomiting. They were admitted as inpatients for implantation of the Wallstent (Boston Scientific Microvasive), which was inserted under fluoroscopic and endoscopic guidance as previously described. 3 Technical success was defined as satisfactory stent deployment and re-establishment of luminal patency. Clinical outcome was recorded in terms of relief of intestinal obstruction and palliation of symptoms.
RESULTS
Twenty-three procedures were attempted in 21 patients, whose details are summarized in Table 1 . Their median age was 75 years (range 40-88). In two-thirds of cases the primary cancer was pancreatic.
Stent implantation was technically successful in 18 (85%) patients. On two occasions a guidewire could not be passed because of the duodenal obstruction and, in a third, a previously placed plastic biliary stent could not be reached for removal, thus preventing enteral stent placement. These 3 patients went on to have a laparoscopic gastrojejunostomy. In all the patients who had successful stent placement, nausea and vomiting improved and caloric intake returned to maintenance levels. There were no short-term complications. Stent migration was seen in only one case, during initial placement. 2 patients who were successfully stented reported abdominal pain after the procedure but this responded to simple analgesia. 2 patients were readmitted with severe vomiting at six and nine months, respectively. In one, tumour had overgrown the edge of the prosthesis; in the other, distortion of the stent itself was causing mechanical obstruction ( Figure 1) . In both cases further coaxial stents were inserted to bridge the stenosis. 17 patients (94%) died during the follow-up period, all from causes unrelated to the stent insertion. Median survival was four months, longest ten months. One patient was lost to follow-up.
DISCUSSION
Our experience with this series, conducted in a district general hospital, supports the findings from major centres 4-6 that more than 70% of patients with malignant upper gastrointestinal strictures not amenable to surgery obtain relief from an endoscopically placed enteral stent. The dearth of information on long-term outcomes reflects the short life expectancy of these patients; mean survival is about thirteen weeks. 5, 7, 8 The reported complications include ulceration caused by the stent wires, 9 bleeding, stent migration, mechanical occlusion, and perforation. 5, 10, 11 Technical difficulties are few. In some instances unfavourable angulation between the oesophagus and gastric antrum, or complete stenosis, makes the guidewire hard to pass. In our early experience there was a tendency to pass the stent distally, which with the forward force generated by opening of the stent led to less than ideal placing. Stent migration was seen in only one case, soon after insertion, and tumour overgrowth in another; we cannot comment on whether these will be commonly encountered in the long term. Perhaps the most troublesome complication is that, over time, the stent can shorten and straighten, leading to duodenal abutment and obstruction (Figure 1 ). In one patient in our care, whose stent was inserted elsewhere, this led to perforation. Further coaxial stents are readily deployed to bypass the obstruction. 
